Primabolan injection by Genesis represents a pure, high-grade formulation of Methenolone Enanthate dosed at 100 mg/ml in a 10ml multi-dose vial. Methenolone is a dihydrotestosterone (DHT) derived anabolic-androgenic steroid celebrated across clinical endocrinology and sports performance for its low androgenic index and total absence of aromatization. Because the molecule resists conversion into estrogens via the aromatase enzyme, athletes utilize this compound to promote lean nitrogen retention and protein synthesis without extracellular water retention or gynecomastia risk.
As an enanthate ester, Genesis Primabolan provides a prolonged, steady release profile into systemic circulation. This allows competitive bodybuilders and athletes seeking muscle tissue preservation during strict caloric deficits to maintain stable physiological levels with infrequent injections. When looking for genuine cutting agents, opting for verified Primobolan preparations ensures tissue preservation, vascularity, and heightened metabolic efficiency.
Due to the long-acting enanthate ester, intramuscular administration should be partitioned evenly throughout the week to stabilize peak plasma concentrations. Genesis Primabolan is oil-based and best administered deep into large muscle bellies such as the gluteal, ventrogluteal, or deltoid regions.
While Primabolan carries a favorable safety profile compared to 19-nor derivatives or harsh C17-alpha alkylated oral compounds, it remains mildly suppressive to the hypothalamic-pituitary-testicular axis (HPTA). Endogenous testosterone synthesis will decline depending on dosage and cycle length. Therefore, a comprehensive post-cycle therapy protocol utilizing SERMs like Clomiphene (Clomid) and Tamoxifen (Nolvadex) is mandatory 14 to 18 days after the final injection.
Methenolone exerts a modest impact on lipid panels by potentially shifting the HDL/LDL ratio. Users are strongly advised to monitor blood lipids, hepatic enzymes, and hematocrit levels before, during, and after cycle completion. Concomitant supplementation with omega-3 fatty acids, citrus bergamot, and adequate hydration supports cardiovascular integrity.
No. Methenolone Enanthate is structurally unable to interact with the aromatase enzyme, meaning it does not convert to estrogen. Users will not experience estrogenic side effects such as subcutaneous water retention or gynecomastia when using Genesis Primabolan in isolation.
Owing to its enanthate ester, which has an active elimination half-life of approximately 10.5 days, injections are typically split into two equal weekly administrations to minimize hormonal fluctuations and maintain stable serum concentrations.
Unlike oral Primobolan (Methenolone Acetate), injectable Methenolone Enanthate is not 17-alpha-alkylated and bypasses first-pass hepatic metabolism. It exhibits negligible liver toxicity; however, standard general health monitoring and baseline liver enzyme panels remain best practice.
